A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.
Qiu W, Zhang C, Wang S, Yu X, Wang Q, Zeng D, Du P, Ma J, Zheng Y, Pang B, Yu Y, Long F, Pang X, Sun Z.
Qiu W, et al. Among authors: yu x, yu y.
J Immunol Res. 2019 Jan 13;2019:3017360. doi: 10.1155/2019/3017360. eCollection 2019.
J Immunol Res. 2019.
PMID: 30733972
Free PMC article.